Principal Financial Group Inc. Sells 656 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Principal Financial Group Inc. cut its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 140,427 shares of the company’s stock after selling 656 shares during the quarter. Principal Financial Group Inc. owned approximately 0.11% of Henry Schein worth $9,618,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of HSIC. Investment Management Corp VA ADV purchased a new position in Henry Schein during the fourth quarter valued at $32,000. Rakuten Securities Inc. purchased a new position in Henry Schein during the first quarter valued at $34,000. UMB Bank n.a. grew its stake in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock valued at $73,000 after acquiring an additional 201 shares in the last quarter. Menard Financial Group LLC purchased a new position in Henry Schein during the fourth quarter valued at $92,000. Finally, Canada Post Corp Registered Pension Plan purchased a new position in Henry Schein during the fourth quarter valued at $95,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Price Performance

HSIC stock opened at $70.68 on Tuesday. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a current ratio of 1.38, a quick ratio of 0.75 and a debt-to-equity ratio of 0.50. The company has a 50-day moving average price of $71.56 and a 200 day moving average price of $71.33. The stock has a market cap of $8.60 billion, a PE ratio of 22.09, a P/E/G ratio of 2.37 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the previous year, the company earned $1.10 EPS. The firm’s revenue for the quarter was down .1% compared to the same quarter last year. Equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Wells Fargo & Company cut their target price on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th. Piper Sandler cut their target price on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research note on Wednesday, April 30th. Robert W. Baird reissued a “neutral” rating and issued a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research note on Monday. Evercore ISI lifted their price objective on shares of Henry Schein from $72.00 to $78.00 and gave the stock an “in-line” rating in a research note on Wednesday, July 9th. Finally, Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research note on Monday. Seven equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $78.36.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.